Chemotherapy agents stimulate dendritic cells against human colon cancer cells through upregulation of the transporter associated with antigen processing
Abstract Single immunotherapy fails to demonstrate efficacy in patients with microsatellite stable (MSS) metastatic colorectal cancer (mCRC). Research on immune reactions before and after systemic agents for mCRC is warranted. Our study examined cell line models to compare the expression of immune s...
Guardado en:
Autores principales: | Yi-Hsin Liang, Jia-Huei Tsai, Yung-Ming Cheng, Kuang-Yu Chan, Wen-Ling Hsu, Chang-Cheng Lee, Kuo-Hsing Chen, Kun-Huei Yeh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/850bbe547505437589968e4bfba8bd88 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cells
por: Yi-Hsin Liang, et al.
Publicado: (2021) -
Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation
por: Fabrizia Bonacina, et al.
Publicado: (2018) -
INTERACTION BETWEEN DENDRITIC CELLS AND B CELLS DURING IMMUNE RESPONSE TO T CELL-INDEPENDENT ANTIGENS
por: D. A. Khochenkov, et al.
Publicado: (2014) -
Human leukocyte antigen class II quantification by targeted mass spectrometry in dendritic-like cell lines and monocyte-derived dendritic cells
por: A. Casasola-LaMacchia, et al.
Publicado: (2021) -
Autophagy Flux Correlates with Upregulation of AKT-1 in RAS Mutated Colon Cancer Cells
por: Hamid Behrouj, et al.
Publicado: (2021)